Xalkori (crizotinib)

pCPA File Number: 21135
Negotiation Status:
Concluded with an LOI
Indication(s):
ROS1-positive advanced Non-Small Cell Lung Cancer
Sponsor/Manufacturer:
Pfizer Canada ULC
CDA-AMC Project Number:
PC0151-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: